Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NPS-1034 |
Trade Name | |
Synonyms | |
Drug Descriptions |
NPS-1034 inhibits AXL and MET, including mutant forms of MET, as well as other kinases, which potentially results in decreased tumor cell growth and may overcome MET or AXL mediated drug resistance (PMID: 24173966, PMID: 24165158). |
DrugClasses | AXL Inhibitor 30 MET Inhibitor 59 |
CAS Registry Number | 1221713-92-3 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Erlotinib + NPS-1034 | Erlotinib NPS-1034 | 0 | 0 |
Gefitinib + NPS-1034 | Gefitinib NPS-1034 | 0 | 0 |
NPS-1034 | NPS-1034 | 1 | 0 |